Company: JUNS
Filing Date: 2025-08-19
Form Type: 10-Q
Source: 0001641172-25-024684
Chunk: 9

Company: JUPITER NEUROSCIENCES, INC.
Filing Date: 2025-08-19
Form: 10-Q
Item: Item 8
Chunk 9
---
 value of the derivative liability. There was no such gain or loss during the three or six months ended June 30, 2025 as the Notes were paid in full in December 2024 eliminating the related derivative liability.

Significant
assumptions utilized in the determination of the fair value of derivative liabilities utilizing a Monte Carlo valuation model were
as follows:

Schedule
of Fair Value Derivative Liability

    June 30, 2024  
  
    Dividend Rate 
     - 
  
    Term 
     0.13 
  
    Volatility 
     90%
  
    Risk-free rate 
     5.0%
  
    Probability of IPO 
     60%

    Derivative liability, measurement input 
     60%

    15

JUPITER
NEUROSCIENCES, INC.

NOTES
TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

JUNE
30, 2025

Note
6 – Stockholders’ Equity

Common
Stock

The
Company is authorized to issue 125,000,000 shares of common stock and 5,000,000 shares of preferred stock. The Company had 34,833,083
shares of common stock issued and outstanding as of June 30, 2025. There were no shares of preferred stock issued and outstanding as of
June 30, 2025.

During
the six months ended June 30, 2025, the Company issued 103,186
shares of common stock, with an aggregate fair value of $66,000,
as consideration for services rendered related to media and investor relations activities,
strategic communications support, enhancement to the Company’s market visibility and shareholder engagement. The fair
value of the shares issued was determined based on the market price of the Company’s common stock at the date of issuance and is included general and administrative expenses in the accompanying 2024 condensed consolidated statement
of operations.

See
Note 6 – Stockholders’ Equity – Restricted Stock Units for additional details regarding the issuance of common
stock upon the vesting of restricted stock units.

Service
Agreement

In
June 2024, The Company entered into service agreements with three separate entities, each with a 36-month term. In connection therewith
the Company issued an aggregate of 3,487,500 restricted shares of common stock, 1,162,500 ratably to each entity with an aggregate fair
value at issuance totaling $4,638,